|
Volumn 123, Issue 11-12, 1997, Pages 674-677
|
Bone and soft tissue sarcomas: Summary of the Third United States/Japan Clinical Trials Summit (Seattle, Washington)
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CISPLATIN;
DACARBAZINE;
DOXORUBICIN;
IFOSFAMIDE;
MESNA;
METHOTREXATE;
N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE;
BONE GRAFT;
CANCER INCIDENCE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED STUDY;
EWING SARCOMA;
FROZEN SECTION;
GENE MUTATION;
HUMAN;
HUMAN TISSUE;
JAPAN;
LIMB SALVAGE;
LIPOSARCOMA;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OSTEOSARCOMA;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SOFT TISSUE SARCOMA;
UNITED STATES;
BONE NEOPLASMS;
CLINICAL TRIALS;
HUMANS;
SARCOMA;
SOFT TISSUE NEOPLASMS;
|
EID: 0031440720
PISSN: 01715216
EISSN: None
Source Type: Journal
DOI: 10.1007/s004320050123 Document Type: Conference Paper |
Times cited : (2)
|
References (0)
|